Cryoablation has emerged as a primary therapy to treat prostate cancer. Although effective, the assumption that freezing serves as a ubiquitous lethal stress is challenged by clinical experience and experimental evidence demonstrating time-temperature-related cell-death dependence. The age-related transformation from an androgen-sensitive (AS) to an androgen-insensitive (AI) phenotype is a major challenge in the management of prostate cancer. AI cells exhibit morphological changes and treatment resistance to many therapies. As this resistance has been linked with a6b4 integrin overexpression as a result of androgen receptor (AR) loss, we investigated whether a6b4 integrin expression, as a result AR loss, contributes to the reported increased freeze tolerance of AI prostate cancer. A series of studies using AS (LNCaP LP and PC-3 AR) and AI (LNCaP HP and PC-3) cell lines were designed to investigate the cellular mechanisms contributing to variations in freezing response. Investigation into a6b4 integrin expression revealed that AI cell lines overexpressed this protein, thereby altering morphological characteristics and increasing adhesion characteristics. Molecular investigations revealed a significant decrease in caspases-8, -9, and -3 levels in AI cells after freezing. Inhibition of a6b4 integrin resulted in increased caspase activity after freezing (similar to AS cells) and enhanced cell death. These data show that AI cells show an increase in post-freeze susceptibility after inhibition of a6b4 integrin function. Further understanding the role of androgen receptor-related a6b4 integrin expression in prostate cancer cells responses to freezing might lead to novel options for neo-adjunctive treatments targeting the AR signaling pathway.
Introduction
Prostate cancer continues to significantly impact many men each year. In 2006, more than 230 000 new cases were diagnosed with nearly 40 000 deaths reported in the United States. 1, 2 For the management of prostate cancer, cryosurgery has emerged as an effective tool for the treatment of localized disease. [3] [4] [5] In 2008 the American Urological Society's Best Practices Panel on Cryosurgery for Localized Prostate Cancer recommended prostate cryoablation as a primary and salvage therapy for all stages of localized disease. 6 This recommendation followed a landmark 10-year retrospective analysis of 370 patients, which showed outcome levels at least equivalent to other therapeutic options (77% cancer free based on sextant biopsy and 80 and 74% PSA negative outcomes for low-and medium-risk patients). 7 This minimally invasive procedure uses the multi-modal destructive forces of the freezing process to effectively ablate targeted tissue [8] [9] [10] in a manner that allows for decreased hospitalization time, reduced postoperative morbidity, rapid return to normal daily activities, and reduced overall treatment cost. [11] [12] [13] [14] [15] [16] [17] Typically, prostate tumors are initially androgen sensitive (AS), and, as such, androgen ablation is a common first line in therapy. Before a cryoablative procedure, androgen ablation is often used to shrink the prostate to a more manageable volume (o50 ml). Although androgen ablation is often initially effective, the therapy often fails within 2 years as the disease progresses to a hormone refractory state 18, 19 due in part to selection pressure (that is selection of androgen-independent cells). This advanced stage disease is often aggressive and metastatic, as well as resistant to many therapeutic options. 20, 21 A compelling link between androgen sensitivity and freeze response was reported in 2008 by Klossner et al. In this study, AS prostate cancer cells were found to be significantly more responsive to freezing damage than androgen-insensitive (AI) cells. This sensitivity difference was directly correlated with the presence or absence of an identifiable androgen receptor (AR). This study reported for the first time that the freeze sensitivity of prostate cancer could be negatively impacted by long-term androgen deprivation. Given the high diagnostic incidence of prostate cancer and the high recurrence rate, 12, 13 strategies to develop and improve primary and salvage treatment options are warranted.
Integrins are extracellular transmembrane (ECM) obligate heterodimeric proteins with non-covalent a and b subunits that mediate external cell functions (such as cell motility, polarity, attachment, and shape) as well as control intracellular signaling pathways that regulate cell proliferation, survival, and apoptosis. 22, 23 For attachment-dependent prostatic cells, integrins form structures that mediate attachment of intracellular intermediate filaments and actin cytoskeleton with ECM proteins (that is collagen, fibronectin, and laminin) and basal cells. 24, 25 a6b4 integrins are a important component of the hemidesmosome expressed at the basal surface in most stratified epithelial cells. Regarding morphology, the a6b4 integrin links the cytoskeleton intermediate filaments (filopodia, lamellae, and retraction fibers) formed on cell borders to laminin-5 in ECM. In normal glandular prostate parenchyma, only the basal cells express integrins connecting them to the substratum. It has been reported that the basal epithelial cell lining is the first morphologic features to be lost in prostate cancer development. 26 The action of the a6b4 integrin has been verified in integrin function blocking studies (specific to a6b4 integrin), which resulted in the slowing of cytoskeletal structure formation. 27 Furthermore, knockout experiments directly confirm that elimination of integrin expression leads to decreases in cell proliferation, adhesion, anchorage-dependent growth, and abnormal cell spreading. 28, 29 In fact, integrins regulate ECM survival cues to such a extent that experiments providing additional ECM (fibronectin) in vitro result in improved survival and anti-apoptotic cellular responses. 30 Furthermore, inhibition of integrin signaling function activates apoptotic cell-death cascades 31 in many cell systems.
Earlier studies have shown that the AR and the androgen signaling pathway are integral in prostate cancer progression and treatment resistance. Bonaccorsi 32-34 and Evangelou 35 have indicated that AR expression directly affects integrin expression. Loss of AR dramatically increases the expression of a6b4 integrins inducing morphological changes, increased cell invasion and proliferation. 32, [36] [37] [38] This AR-mediated upregulation in AI cells is important because integrin signaling thereby activates proliferation and survival cues, resulting in cancer progression. 29, 33, 34, [39] [40] [41] [42] Integrin expression has also been shown to influence cell survival after cryopreservation. 43 More specifically, the freezing process causes damage to microtubules and actin filament structural support fibers by extracellular ice, thermal contraction, alteration in intracellular solute levels, pH, and so on. Together these mechanisms disrupt integrin-mediated substrate attachment and intracellular signaling pathways, which are essential for cell survival. 44, 45 In this study, we investigated the influence of integrin expression in prostate cancer cell response to freezing injury. Furthermore, we explored the potential of integrin inhibition as an adjunctive approach to increasing cryosurgical efficacy in both AS and AI prostate cancer. Although it is appreciated that temperature of oÀ40 1C typically results in complete cell destruction, studies have shown that at temperatures associated with the margin or periphery of the cryogenic lesion (iceball) there maybe a degree of cell survival and as such the potential for cancer reoccurrence. As such, this study focused on temperatures associated with the iceball margin as a means of understanding cellular response and improving cryoablation efficacy. Our data show that the inhibition of integrin activity during freezing leads to substantial increases in apoptotic cascade activity and cell death in prostate cancer cells. Furthermore, we find differential responses to in AS vs AI prostate cancer cells to integrin inhibition.
Materials and methods

Cell culture
The AS human prostate cancer cell line, LNCaP (LNCap LP), was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). The PC-3 AR cell line (AS) was transfected with the full-length AR and selected for stable expression, and the PC-3 cell line (androgen independent, AI) was transfected with an empty vector. Both lines were obtained from Dr Joachim B Schnier (Department of Biochemistry and Molecular Medicine at the University of California at Davis 46 ). The LNCaP HP (high passage) cell line (AI) was created by repeated culture (over 60 passages) of the LNCaP cell line in low-hormone medium (RPMI-1640 supplemented with 10% charcoal stripped serum (Biomedia, Manistique, MI, USA) and 1% penicillin/streptomycin (Mediatech Inc., Herndon, VA, USA)). Cultures were maintained at 37 1C, 5% CO 2 /95% air in RPMI-1640 growth medium (Cassion Laboratories, North Logan, UT, USA) supplemented with 10% fetal calf serum (Atlanta Biologicals, Lawrenceville, GA, USA) and 1% penicillin/streptomycin (Mediatech Inc.). PC-3 AR culture media was supplemented with 100 mg ml À1 hygromycin B (Calbiochem, San Diego, CA, USA). Cultures were grown in Falcon 75 cm 2 T-flasks with media exchange every 3 days. Experimental subcultures were prepared in Costar 96-well, removable strip plates at 18 000 cells per well.
Freezing protocol
Costar strip wells (100 ml medium per well) were placed into an aluminum block partially submerged in a cooling bath pre-set to the target temperature. The sample temperature was monitored with a type-T thermocouple with measurements taken at regular intervals. To prevent sample super-cooling, ice nucleation was initiated by contact with a cold metallic probe when sample temperature reached À2 1C (±1 1C). After nucleation, samples were held for an additional 12 min (15 min total) to allow for thermal equilibration. Samples were then allowed to thaw at room temperature and once completely thawed returned to normothermic culture conditions.
Cell viability
Cell viability was assessed using the alamarBlue assay (Invitrogen, Carlsbad, CA, USA) in HBSS (1:20 dilution) Freezing outcome is affected by integrin expression JG Baust et al every other day after the freezing insult. Cell cultures were exposed to alamarBlue for 1 h at 37 1C and then analyzed using a Tecan SPECTRAFluorPlus plate reader (TECAN Austria GmbH) with an excitation of 530 nm and emission of 590 nm. Subsequently, cell culture media were replenished and returned to normal culture.
Integrin function blocking assay
Blocking of a6b4 integrin function was accomplished by incubating cells in suspension (180 000 cells per ml) in the presence of 40 mg ml À1 anti-a6b4 integrin anti-a6, and anti-b4 antibodies (Chemicon International, Billerica, MA, USA) for 1 h at 37 1C. Subsequently, cells were plated into 96-well Costar strip plates at 18 000 cells per well, and cultured for 24 h. Samples were then frozen after a 24 h post-exposure recovery period.
Fluorescent imaging
To assess the mode of freeze-associated cell death, cells were cultured in Costar 96-well, strip plates and frozen to À15 1C for 15 min. Samples were then assessed through triple labeling using the fluorescent probes (Molecular Probes, Eugene, OR, USA) Hoechst (blue fluorescence, 0.06 mg ml À1 ), propidium iodide (red fluorescence, 0.007 mg ml À1 ), and YO-PRO-1 (green fluorescence, 0.8 mM) to detect living cells, necrotic cells (freezeruptured), and apoptotic cells, respectively. Probes were added to each sample and incubated in the dark for 20 min. After incubation, samples were visualized through fluorescence microscopy using a Zeiss Axiovert 200M microscope at Â 240 magnification.
Western blot
Samples were cultured in 100 mm Petri dishes and frozen at À15 1C for 15 min. Cell lysates (detached and adherent) were collected on ice at 1, 3, 6, 12, and 24 h post-thaw using ice-cold radio-immunoprecipitation assay cell lysis buffer with phosphatase inhibitor (sodium fluoride 1 mM, sodium orthovanadate 1 mM, sodium pyrophosphate 1 mM), leupeptin (1 ug ml À1 ), phenylmethylsulphonylfluoride 1 mM, and 1 Â Halt Protease Cocktail Inhibitor (Pierce, Rockford, IL, USA). Samples were homogenized by vortex mixing and centrifuged at 16 000 g for 15 min at 4 1C. Protein concentrations were determined using the bicinchonic acid protein assay (Pierce) and quantified using a Tecan SpectraFluorPlus spectrophotometer. Equal amounts of protein (25 mg) were loaded for each sample and separated on a 10% SDS-PAGE gel (Bio-Rad, Hercules, CA, USA). Proteins were transferred to PVDF membranes (Bio-Rad), blocked with 3% BSA solution containing 0.05% Tween-20, and incubated at 4 1C overnight in the presence of each antibody (anti-human b-tubulin (BD Pharmingen), anti-human a6 integrin (Chemicon International), anti-human b4 integrin (Chemicon International), anti-human AKt (Cell Signaling, Beverly, MA, USA), or anti-human pAKt (Cell Signaling)). Membranes were then washed three times with 0.05% Tween-20 in PBS and exposed with horseradish peroxidase-conjugated secondary antibodies. Membranes were visualized using a Fujifilm LAS-3000 luminescent image analyzer for detection. All protein levels were compared with tubulin (protein loading control) and quantitative assessment was conducted through densometric analysis using the Fuji software.
Caspase activity assays
Protein samples for caspases-3, -8, -9 activity assays were collected from samples in 100 mm Petri dishes frozen at À15 1C for 15 min. Cell lysates were collected on ice at 1, 3, 6, 12, and 24 h post-thaw using ice-cold radioimmunoprecipitation assay cell lysis buffer without protease or phosphatase inhibitors. Protein concentrations were quantified and assessed. Equal amounts of protein (50 mg) were assessed in duplicate for caspase activity using the BD ApoAlert Caspase Fluorescent Assay kits for caspases-3, -8, and -9. Sample fluorescence (caspase activity) was quantified using the TECAN spectrofluorometer and converted to fold change in activity based on non-frozen control values.
Data analysis
Fluorescence units were converted to percent survival based on non-frozen experimental control (37 1C). Viability experiments were repeated a minimum of three times with an intra-experiment repeat of eight replicates. Western blot fluorescent imaging and protease activity assays were conducted on a minimum of three separate experiments. Calculations of standard error were performed and statistical significance was determined by single-factor analysis of variance (ANOVA).
Results
Cell adhesion is affected in AI cells by increased expression of a6b4 integrins
It is known that morphological changes occur during prostate cancer progression from AS to AI phenotypes, and ECM proteins have been reported to be involved with these changes. 34, 47 Earlier studies have shown these phenomena in both the LNCaP and PC-3 cell lines used in this study. 48 Specifically, it has been shown that the LNCaP HP and PC3 cells lines are AI whereas the LNCaP LP and PC3-AR are AS cells. However, it is not known if changes in integrin expression are involved with the reported freeze difference in responses of AS and AI prostate cancer. Phase-contrast microscopy reveals that significant morphological changes occur with transition to AI (Figure 1 ). LNCaP LP (AS) exhibit large, slender, cytoplasmic projections that form prominent spaces between adjacent cells. Interestingly, LNCaP HP (AI) lack cell projections allowing cells to proliferate within close proximity. PC-3 AR (AS) exhibited broad cytoskeletal attachment allowing fewer cells to proliferate per unit area, whereas many more PC-3 cells (AI) were able to concentrate into a given area.
With the observed morphological alterations, investigations into the molecular basis that may be responsible for attachment-related changes and the possible involvement of integrins were conducted. Furthermore, the effect of freezing on integrin expression was also examined for its potential influence on cellular freeze response. Western blot analysis of integrin expression Figure 2 ). AS (LNCaP LP and PC-3 AR) cells exhibited significantly lower levels of both a6 and b4 integrin subunits overall. Additionally, the AS cells exhibited a temporal decrease in both a6 and b4 subunits post-freeze. AI cells (LNCaP HP and PC-3) exhibited greater basal levels of b4 and a6 integrin subunits. Furthermore, it was found that after a freeze insult, the AI cells showed a temporal increase in integrin levels ( Figure 2 ). Specifically, it was found that 12 h after freezing, a peak in b4 levels occurred whereas a peak in a6 levels was found 24 h post-freeze. These data show a unique response of AI cells after freezing where integrin levels increased significantly compared to the AS cells. With the direct connection between integrin expression and cell survival/proliferation pathways, and earlier reports showing the increase freeze resistance of AI prostate cancer cells, it seemed plausible that integrin expression and resistant signal transduction pathways may directly affect cell response to freezing.
Inhibition of integrin function during freezing decreases AI cell viability more significantly than AS cell viability
Studies with AI prostate cancer cells, which express greater levels of a6b4 integrin as a result of AR loss, have shown that increased a6b4 integrin ECM cell signaling correlates with greater freeze resistance. 32, [36] [37] [38] To further investigate a6b4 integrin influence on freeze response, competitive antibody inhibition studies using anti-a6 and anti-b4 integrin antibodies were conducted to block integrin signaling and function. Samples were frozen and post-thaw recovery (1-7 days) was assessed ( Figure 3 ). Analysis of cell viability over the 7-day recovery period revealed that each of the surviving populations recovered and that the rate of recovery was proportional to the initial day 1 survival. Interestingly, different freeze responses were observed in AS and AI. AS cells exhibited a decrease in day 1 post-freeze cell viability after exposure to integrin function blocking compared to freeze alone (Figure 3a) . Although separate blocking of a6 and b4 integrin functions yielded decreases in postfreeze cell viability, blocking the a6b4 complement had the greatest effect on reducing post-freeze viability. With inhibition of a6b4 integrin function, LNCaP LP exhibited an overall decrease in post-freeze viability of 10.1 ± 0.5% from freeze alone (7% vs 17%, respectively, Po0.01). Similar results were observed from the AS PC-3 AR cells in which blocking of the a6b4 complex resulted in an 18% reduction in overall cell survival compared with cells frozen to À15 1C without blocking (30% vs 12%, respectively Po0.01) (data not shown). Interestingly, compared with AS cells, AI cells exhibited a much greater reduction in post-freeze cell survival after the integrin function blocking assay (Po0.05), indicating greater dependence on that signaling mechanism (Figure 3b) . Similarly, inhibition of separate subunits yielded lesser reductions in post-freeze cell viability vs the inhibition of both subunits. For a6b4 integrin function inhibition, LNCaP HP exhibited a decrease in post-freeze cell viability of 28.7 ± 0.7% overall (27% vs 56%, respectively, Po0.01). The greater sensitivity of AI cell lines to disruption of integrin signaling pathways indicated a putative influence of integrin signaling on cell survival after a freezing insult. Furthermore, through the integrin a6b4 complex blocking, AI cell susceptibility to freezing injury was similar to that of the native AS cell populations, which contained lower basal integrin expression levels. These data reveal that integrins have a substantial function in cell response to freezing.
Integrin function-blocked AI prostate cell lines exhibited differentially increased freezing-induced apoptosis and necrosis
The significant reduction in post-freeze viability observed in the AI cells as a result of a6b4 integrin function inhibition prompted the investigation into what modes of cell death were affected. Thus, to evaluate total levels and temperature characteristics in terms of apoptotic and necrotic cell death after freezing, a6b4 integrin blocking assays were conducted. Samples were frozen to À15 1C and assessed by a triple-fluorescent probe (Hoechst (blue)) to assess viable cells, propidium iodide (red) to assess necrotic cells, and YO-PRO-1 (green) to assess Similar results were again noted with the AS PC-3 AR cells (data not shown). These data indicated that a6b4 integrin blocking during freezing did not significantly (P40.05) alter the apoptotic and necrotic cell-death cascades in the AS cell populations. Compared with AS cell lines, the AI cells, when subjected to freezing, exhibited lower levels of overall apoptosis and necrosis. Apoptosis and necrosis were minimal in control (unfrozen) samples. After freeze exposure, apoptotic and necrotic levels increased with a shift in peak apoptotic activity at 6 h post-freeze with a rapid decline by 24 h. Furthermore, the overall levels of both apoptosis and necrosis were significantly lower in the AI vs AS cell populations. Comparison of the freeze only AI samples with the a6b4 integrin blocking samples revealed that the functional blocking resulted in a substantial increase in the level of apoptotic cell death post-thaw. Post-freeze time points revealed increased levels of apoptosis and necrosis with peak levels occurring after 3 h post-freeze, which represented a more rapid apoptotic induction compared with freeze alone. Quantitative analysis for freeze alone at 3 h post-freeze revealed the following: indicating that AI cell lines are more greatly affected by integrin inhibition. The data suggest that the increased integrin level in the AI cell population is responsible for the increased resistance to freezing-injury. Fluorescent micrographic and viability data support the notion of increased integrin levels having a critical role in AI prostate cancer cell survival. To further investigate these phenomena, apoptotic cell-death signal transduction pathway proteins (caspases) were analyzed to determine both the effect of freezing as well as integrin blocking. Representative caspases were selected based on their association with either membrane-linked (caspase-8) or mitochondrial-linked (caspase-9) apoptotic induction. Additionally, analysis of the down stream executioner caspase-3 was also conducted to verify signal transduction leading to cell death (Figures 5a-c) . Analysis of caspase-8 after freezing revealed a high degree of activity peaking 3 h post-freeze in the AS LNCaP population (Figure 5a ). This level of activity was consistent in both the freeze only and integrin-blocked samples. Analysis of the AI LNCaP HP samples revealed a substantial reduction in caspase-8 activity after freezing. Interestingly, when integrins were blocked, the AI cells showed a marked increase in caspase-8 activity compared with freeze only samples. This increase in activity was observed to be greater than 2.8-fold (2.6 relative fluorescence units (RFU) vs 7.5 RFU, respectively). These data show a marked alteration in caspase-8 (membrane-linked apoptosis) levels after freezing and integrin blocking. Investigation of the effect of freezing on caspase-9 activity (mitochondrial-linked apoptosis) revealed that after freezing there was a marked increase in caspase-9 activity. This increase was similar to that observed with caspase-8 activity (Figure 5b) . In contrast to caspase-8, integrin blocking was much less effective on caspase-9 activity overall in both the AS and AI populations. Peak caspase-9 activities increased from 10 RFU to 17 RFU in the AI LNCaP HP samples as a result in integrin blocking, which represented less than a 0.7-fold change. This was in stark contrast to the greater than 2.8fold increase in caspase-8 activity. Analysis of down stream transduction of apoptotic signals revealed that after freezing, caspase-3 was also activated in both the AS and AI populations (Figure 5c ). It was further noted that there was little alteration in caspase-3 activity between the freeze only and integrin-blocked AS cell populations.
In the AI cells, integrin blocking resulted in a significant increase in overall caspase-3 activity. These data (B2.5fold increase) suggest that the activation of caspase-8 by integrin blocking translated into an increase in cell death. Similar results for caspases-8, -9, and -3 activity after freezing and integrin blocking were also observed in the AS PC-3 AR and AI PC-3 cell populations.
Discussion
Cryosurgery is an option for treating either early or advanced stage (localized) prostate cancer and its efficacy has been well documented. 12, 49 For patients with localized (early or advanced stage) prostate cancer, cryosurgery demonstrates superior efficacy and improved long-term disease-free control. Despite successes in disease treatment, cryosurgery still experiences low, yet significant, recurrence rates that are greater for advanced stage carcinomas. 12, 13 Furthermore, the progression of prostate cancer to an AI, treatment resistant form (reviewed in 50 ) remains a therapeutic challenge, especially as increased integrin expression has been implicated with advanced stage disease. 24, 28, 51 Therefore, we examined whether or not changes in AR expression (AS to AI) affected a6b4 integrin expression resulting in changes of prostate cancer tolerance to freezing. We showed that AI cells, which lack AR expression, exhibited increased levels of a6b4 integrin expression, which correlated significantly with increased post-freeze survival by mediating reduced caspase activity. Similarly, Pawar et al. 52 reported on a6 integrin cleavage as a feasible sensitizer for human prostate cancer to ionizing radiation. In this regard, the ECM environment changes dramatically after radiation therapy, which like cryoablation alters the soluble and insoluble components of ECM. Importantly, the ability of the tumor cell to survive radiation therapy or cryoablation seems to be dependent on the level of integrin expression on the cell surface.
In this study, we investigated the changes that occurred in integrin expression between AS and AI cells and their influence on freezing response. It has been recognized for many years that morphological changes in prostate cancer occur as tumors progress to advanced disease. In fact, this morphological progression is the basis underlying the Gleason scale of prostate cancer differentiation. The initial identification of a6b4 integrin as a significant molecular difference between AS and AI cells resulted from recent studies showing that AR-mediated a6b4 integrin expression is responsible for morphological changes in filopodia and lamellae formation as observed in our model prostate cancer cell lines [32] [33] [34] 53 (Figure 1) .
Investigation into the involvement of a6b4 integrin in freeze response stemmed from a report by Klossner et al. 48, 54 showing the freeze tolerance differential between AS and AI prostate cancer cells. Other studies showed that the cytoskeleton is a major target in freezeinduced cell death. 43 Western blot analysis of a6b4 integrin expression post-freeze further indicated that ECM protein expression might affect freezing survival through a reduction of apoptosis and increase in cell attachment and survival signaling. The increase in integrin signaling could provide for survival signaling to intercellular pathways through intermediate filaments, actin filaments, and kinase pathways such as the PI3K/AKt pathway. 44, 45 The results of this study support this hypothesis and show that increased integrin attachment and signaling resulted in increased cell survival after freezing. Furthermore, the importance of a6b4 integrin expression in freeze response was verified using a function blocking assay, which demonstrated that AS cells exhibited a statistically smaller decrease in post-freeze viability compared with AI cells. These studies revealed that the increased freeze survival of AI cells was reduced by a6b4 integrin inhibition to levels comparable with AS cells treated with freeze alone.
The significant increase in cell death in AI cells with inhibited a6b4 integrin prompted the investigation into which alterations in cell-death pathways might have occurred. Studies have shown that integrins regulate the apoptotic processes, 30, 31 but their role in the freeze response of AS and AI cells remained unknown. Fluorescent micrographic analysis provided a qualitative assessment showing that a6b4 integrin function-blocked AI cells exhibited a significant increase in caspase activity peaking at 3 h post-freeze (vs 6 h post-freeze for freeze alone). Caspase activity assays provided qualitative analysis, corroborating an increase in the levels of apoptotic activity in AI cells after integrin blocking. Caspase-3 activity analysis revealed that, compared to freeze alone at À15 1C, a6b4 integrin function-blocked AS cells showed slight increases in caspase-3 activity, whereas in the AI cells a substantial increase in caspase activity was observed by integrin blocking. Furthermore, AI cell lines exhibited increased caspase-3 activation (up to 24 h post-freeze), which contrasted with freeze alone that showed declining caspase-3 activity over the same interval. This finding indicates that a6b4 integrin inhibition resulted in greater relative apoptotic activity in AI cells leading to a reduction in post-freeze viability. After integrin blocking, AI cells showed caspase-3 activity levels that were comparable with those observed for AS cells. Werner et al. 55 noted that increases in integrinrelated caspase-3 activity result from disrupted hemidesmosome assembly, which may also occur in the freezing processes. A similar differential increase in caspase-8 activity was observed for AI cells compared with AS cells. This alteration in caspase-8 activity indicates that a6b4 integrin inhibition during freezing resulted in an activation of the membrane-mediated apoptotic pathway. These findings are in accord with research showing that integrin signaling and caspase-8 activity are linked. 56 Taken together, these findings indicate that inhibition of integrin signaling pathways might lead to 'cross-talk' with transmembrane receptors to increase membrane-mediated apoptotic cell death when cells are unable to receive survival signaling from cell attachment proteins. Finally, caspase-9 showed similar differential increases for AI cells. However, compared to caspase-8 activity increases, the increase in caspase-9 activity suggests that integrin-related activation of both the membrane and mitochondriallinked signaling pathways may be involved in the overall AI cell response to freezing. Additionally, caspase-9 exhibited peak activity at 3 h, which indicates a shift to earlier apoptotic activation (compared with 6 h for freeze alone).
In conclusion, the data support the hypothesis that AR-mediated changes in integrin expression differentially affects the freeze responses of AS and AI prostate cancer cells. Increased a6b4 integrin expression as a result of AR loss resulted in reduced caspase activity, which could be transiently reversed through integrinbinding inhibition. Studies have shown that cell adhesion and the accompanying cytoskeletal elements are important factors in treatment resistance of advanced malignant disease, 57 and the identification of a6b4 integrin as a mediator of freeze response provides an exciting opportunity to increase the efficacy of cryosurgery through neo-adjuvant treatment options. Reports by our group [58] [59] [60] and Le Pivert 61 have detailed the advantages of using neo-adjunctive, low-dose chemotherapeutic agents to weaken prostate tumors before cryosurgery, which has shown to be effective beyond that of either treatment alone. Thus, it may be possible to adjust extant integrin targeting treatments 62 to inhibit a6b4 integrin, which may be overexpressed in prostate cancer, and combine that therapy with cryotherapy to achieve reduced prostate cancer disease recurrence and increase patient quality of life.
